Myomo (NYSE:MYO) shares were down this morning on fourth-quarter results that were mixed compared to the consensus forecast. The Boston-based medical robotics company posted losses of $2.7 million, or 52¢ per share, on sales of $4 million for the three months ended Dec. 31, 2021, for a bottom-line slide deeper into the red on sales […]
myomo
Myomo touts independent study of its MyoPro myoelectric orthosis
Myomo (NYSE:MYO) announced today that new research demonstrated benefits with its MyoPro myolectric orthosis for the upper limbs. Results from the study, funded by the U.S. Army Medical Research Acquisition Activity, and supported by the Office of Secretary of Defense for Health Affairs, were published in the peer-reviewed journal Frontiers in Neurology. Data showed “statistically significant improvements” […]
Myomo skyrockets after hours on Street-beating Q3
Myomo (NYSE:MYO) shares got a big boost after hours today on third-quarter results that came in ahead of the consensus forecast. MYO shares were up 10.9% at $11.52 per share after hours. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down 0.9%. The Boston-based […]
Myomo ticks up on Street-beating Q2 results
Myomo (NYSE:MYO) posted second-quarter results this week that beat the overall consensus on Wall Street. The Boston-based medical robotics company — maker of MyoPro powered arm braces — reported losses of -$2.6 million, or -46¢ per share, on sales of $3.1 million for the three months ended June 30, for a sales growth of 261.56% compared […]
Myomo rises on Street-beating Q4
Myomo (NYSE:MYO) shares ticked up this morning on fourth-quarter results that topped the consensus forecast. The Boston-based wearable medical robotics company posted losses of -$1.7 million, or -37¢ per share, on sales of $3.8 million for the three months ended Dec. 31, 2020, for a 38.5% bottom-line gain on revenues that were more than doubled […]
Myomo rises after hours on more than 200% revenue increase
Myomo (NYSE:MYO) shares ticked up after hours today on third-quarter results that topped the consensus forecast. MYO shares were up 15.9% at $5.60 per share after hours. The Cambridge, Mass.-based company posted losses of -$2.8 million, or -70¢ per share, on sales of $1.9 million for the three months ended Sept. 30, 2020, for a slight […]
Myomo names chief medical officer
Myomo (NYSE:MYO) today said it appointed Dr. Harry Kovelman as chief medical officer, effective immediately. Kovelman will be responsible for overseeing the company’s patient advocacy organization. He will work with commercial and government payer organizations to increase patient access to the MyoPro product line. “I’m pleased to welcome Dr. Kovelman to Myomo as we continue to […]
